Literature DB >> 22190494

The c-MYC oncoprotein, the NAMPT enzyme, the SIRT1-inhibitor DBC1, and the SIRT1 deacetylase form a positive feedback loop.

Antje Menssen1, Per Hydbring, Karsten Kapelle, Jörg Vervoorts, Joachim Diebold, Bernhard Lüscher, Lars-Gunnar Larsson, Heiko Hermeking.   

Abstract

Silent information regulator 1 (SIRT1) represents an NAD(+)-dependent deacetylase that inhibits proapoptotic factors including p53. Here we determined whether SIRT1 is downstream of the prototypic c-MYC oncogene, which is activated in the majority of tumors. Elevated expression of c-MYC in human colorectal cancer correlated with increased SIRT1 protein levels. Activation of a conditional c-MYC allele induced increased levels of SIRT1 protein, NAD(+), and nicotinamide-phosphoribosyltransferase (NAMPT) mRNA in several cell types. This increase in SIRT1 required the induction of the NAMPT gene by c-MYC. NAMPT is the rate-limiting enzyme of the NAD(+) salvage pathway and enhances SIRT1 activity by increasing the amount of NAD(+). c-MYC also contributed to SIRT1 activation by sequestering the SIRT1 inhibitor deleted in breast cancer 1 (DBC1) from the SIRT1 protein. In primary human fibroblasts previously immortalized by introduction of c-MYC, down-regulation of SIRT1 induced senescence and apoptosis. In various cell lines inactivation of SIRT1 by RNA interference, chemical inhibitors, or ectopic DBC1 enhanced c-MYC-induced apoptosis. Furthermore, SIRT1 directly bound to and deacetylated c-MYC. Enforced SIRT1 expression increased and depletion/inhibition of SIRT1 reduced c-MYC stability. Depletion/inhibition of SIRT1 correlated with reduced lysine 63-linked polyubiquitination of c-Myc, which presumably destabilizes c-MYC by supporting degradative lysine 48-linked polyubiquitination. Moreover, SIRT1 enhanced the transcriptional activity of c-MYC. Taken together, these results show that c-MYC activates SIRT1, which in turn promotes c-MYC function. Furthermore, SIRT1 suppressed cellular senescence in cells with deregulated c-MYC expression and also inhibited c-MYC-induced apoptosis. Constitutive activation of this positive feedback loop may contribute to the development and maintenance of tumors in the context of deregulated c-MYC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22190494      PMCID: PMC3268300          DOI: 10.1073/pnas.1105304109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  88 in total

1.  Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses.

Authors:  Wen Yong Chen; David H Wang; Raywhay Chiu Yen; Jianyuan Luo; Wei Gu; Stephen B Baylin
Journal:  Cell       Date:  2005-11-04       Impact factor: 41.582

2.  Second-generation shRNA libraries covering the mouse and human genomes.

Authors:  Jose M Silva; Mamie Z Li; Ken Chang; Wei Ge; Michael C Golding; Richard J Rickles; Despina Siolas; Guang Hu; Patrick J Paddison; Michael R Schlabach; Nihar Sheth; Jeff Bradshaw; Julia Burchard; Amit Kulkarni; Guy Cavet; Ravi Sachidanandam; W Richard McCombie; Michele A Cleary; Stephen J Elledge; Gregory J Hannon
Journal:  Nat Genet       Date:  2005-10-02       Impact factor: 38.330

3.  Metabolic signatures associated with a NAD synthesis inhibitor-induced tumor apoptosis identified by 1H-decoupled-31P magnetic resonance spectroscopy.

Authors:  Manickam Muruganandham; Alan A Alfieri; Cornelia Matei; Yuchun Chen; George Sukenick; Isabel Schemainda; Max Hasmann; Leonard B Saltz; Jason A Koutcher
Journal:  Clin Cancer Res       Date:  2005-05-01       Impact factor: 12.531

4.  Cancer-specific functions of SIRT1 enable human epithelial cancer cell growth and survival.

Authors:  Jack Ford; Ming Jiang; Jo Milner
Journal:  Cancer Res       Date:  2005-11-15       Impact factor: 12.701

5.  Caspase-dependent processing activates the proapoptotic activity of deleted in breast cancer-1 during tumor necrosis factor-alpha-mediated death signaling.

Authors:  Ramya Sundararajan; Guanghua Chen; Chandreyee Mukherjee; Eileen White
Journal:  Oncogene       Date:  2005-07-21       Impact factor: 9.867

6.  Inhibition of SIRT1 catalytic activity increases p53 acetylation but does not alter cell survival following DNA damage.

Authors:  Jonathan M Solomon; Rao Pasupuleti; Lei Xu; Thomas McDonagh; Rory Curtis; Peter S DiStefano; L Julie Huber
Journal:  Mol Cell Biol       Date:  2006-01       Impact factor: 4.272

7.  Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors.

Authors:  C A Bradbury; F L Khanim; R Hayden; C M Bunce; D A White; M T Drayson; C Craddock; B M Turner
Journal:  Leukemia       Date:  2005-10       Impact factor: 11.528

8.  The ubiquitin ligase HectH9 regulates transcriptional activation by Myc and is essential for tumor cell proliferation.

Authors:  Sovana Adhikary; Federica Marinoni; Andreas Hock; Esther Hulleman; Nikita Popov; Rudi Beier; Sandra Bernard; Micaela Quarto; Maria Capra; Stephan Goettig; Ulrike Kogel; Martin Scheffner; Kristian Helin; Martin Eilers
Journal:  Cell       Date:  2005-11-04       Impact factor: 41.582

9.  Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1.

Authors:  Joseph T Rodgers; Carlos Lerin; Wilhelm Haas; Steven P Gygi; Bruce M Spiegelman; Pere Puigserver
Journal:  Nature       Date:  2005-03-03       Impact factor: 49.962

10.  Immortalization of primary human prostate epithelial cells by c-Myc.

Authors:  Jesús Gil; Preeti Kerai; Matilde Lleonart; David Bernard; Juan Cruz Cigudosa; Gordon Peters; Amancio Carnero; David Beach
Journal:  Cancer Res       Date:  2005-03-15       Impact factor: 13.312

View more
  132 in total

1.  SIRT6 deacetylase activity regulates NAMPT activity and NAD(P)(H) pools in cancer cells.

Authors:  Giovanna Sociali; Alessia Grozio; Irene Caffa; Susanne Schuster; Pamela Becherini; Patrizia Damonte; Laura Sturla; Chiara Fresia; Mario Passalacqua; Francesca Mazzola; Nadia Raffaelli; Antje Garten; Wieland Kiess; Michele Cea; Alessio Nencioni; Santina Bruzzone
Journal:  FASEB J       Date:  2018-12-04       Impact factor: 5.191

2.  The Cellular Protein Complex Associated with a Transforming Region of E1A Contains c-MYC.

Authors:  S Vijayalingam; T Subramanian; Ling-Jun Zhao; G Chinnadurai
Journal:  J Virol       Date:  2015-11-11       Impact factor: 5.103

3.  SIRT1 is a Highly Networked Protein That Mediates the Adaptation to Chronic Physiological Stress.

Authors:  Michael W McBurney; Katherine V Clark-Knowles; Annabelle Z Caron; Douglas A Gray
Journal:  Genes Cancer       Date:  2013-03

4.  SIRT1: Regulator of p53 Deacetylation.

Authors:  James T Lee; Wei Gu
Journal:  Genes Cancer       Date:  2013-03

5.  The diversity of histone versus nonhistone sirtuin substrates.

Authors:  Paloma Martínez-Redondo; Alejandro Vaquero
Journal:  Genes Cancer       Date:  2013-03

6.  Sin3b interacts with Myc and decreases Myc levels.

Authors:  Pablo Garcia-Sanz; Andrea Quintanilla; M Carmen Lafita; Gema Moreno-Bueno; Lucia García-Gutierrez; Vedrana Tabor; Ignacio Varela; Yuzuru Shiio; Lars-Gunnar Larsson; Francisco Portillo; Javier Leon
Journal:  J Biol Chem       Date:  2014-06-20       Impact factor: 5.157

Review 7.  The multifaceted functions of sirtuins in cancer.

Authors:  Angeliki Chalkiadaki; Leonard Guarente
Journal:  Nat Rev Cancer       Date:  2015-09-18       Impact factor: 60.716

8.  MYC Disrupts the Circadian Clock and Metabolism in Cancer Cells.

Authors:  Brian J Altman; Annie L Hsieh; Arjun Sengupta; Saikumari Y Krishnanaiah; Zachary E Stine; Zandra E Walton; Arvin M Gouw; Anand Venkataraman; Bo Li; Pankuri Goraksha-Hicks; Sharon J Diskin; David I Bellovin; M Celeste Simon; Jeffrey C Rathmell; Mitchell A Lazar; John M Maris; Dean W Felsher; John B Hogenesch; Aalim M Weljie; Chi V Dang
Journal:  Cell Metab       Date:  2015-09-17       Impact factor: 27.287

9.  Gerometabolites: the pseudohypoxic aging side of cancer oncometabolites.

Authors:  Javier A Menendez; Tomás Alarcón; Jorge Joven
Journal:  Cell Cycle       Date:  2014-02-03       Impact factor: 4.534

10.  Geroncogenesis: metabolic changes during aging as a driver of tumorigenesis.

Authors:  Lindsay E Wu; Ana P Gomes; David A Sinclair
Journal:  Cancer Cell       Date:  2014-01-13       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.